These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 7055803

  • 1. Chlorpromazine distribution in hamsters and mice bearing transplantable melanoma.
    Fairchild RG, Greenberg D, Watts KP, Packer S, Atkins HL, Som P, Hannon SJ, Brill AB, Fand I, McNally WP.
    Cancer Res; 1982 Feb; 42(2):556-62. PubMed ID: 7055803
    [Abstract] [Full Text] [Related]

  • 2. Melanin content of hamster tissues, human tissues, and various melanomas.
    Watts KP, Fairchild RG, Slatkin DN, Greenberg D, Packer S, Atkins HL, Hannon SJ.
    Cancer Res; 1981 Feb; 41(2):467-72. PubMed ID: 7448793
    [Abstract] [Full Text] [Related]

  • 3. Selective targeting of boronophenylalanine to melanoma in BALB/c mice for neutron capture therapy.
    Coderre JA, Glass JD, Fairchild RG, Roy U, Cohen S, Fand I.
    Cancer Res; 1987 Dec 01; 47(23):6377-83. PubMed ID: 3677082
    [Abstract] [Full Text] [Related]

  • 4. In vitro and in vivo evaluation of o-carboranylalanine as a potential boron delivery agent for neutron capture therapy.
    Yong JH, Barth RF, Wyzlic IM, Soloway AH, Rotaru JH.
    Anticancer Res; 1995 Dec 01; 15(5B):2033-8. PubMed ID: 8572598
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of growth of transplantable melanotic melanoma in golden hamsters (Mesocricetus auratus, Waterhouse) by chlorpromazine.
    Zbytniewski Z, Drewa G.
    Arch Immunol Ther Exp (Warsz); 1973 Dec 01; 21(6):871-5. PubMed ID: 4206275
    [No Abstract] [Full Text] [Related]

  • 6. The hamster cheek pouch as a model of oral cancer for boron neutron capture therapy studies: selective delivery of boron by boronophenylalanine.
    Kreimann EL, Itoiz ME, Dagrosa A, Garavaglia R, Farías S, Batistoni D, Schwint AE.
    Cancer Res; 2001 Dec 15; 61(24):8775-81. PubMed ID: 11751398
    [Abstract] [Full Text] [Related]

  • 7. Improvement of the tumor-suppressive effect of boron neutron capture therapy for amelanotic melanoma by intratumoral injection of the tyrosinase gene.
    Morita N, Hiratsuka J, Kondoh H, Uno M, Asano T, Niki Y, Sakurai Y, Ono K, Harada T, Imajo Y.
    Cancer Res; 2006 Apr 01; 66(7):3747-53. PubMed ID: 16585201
    [Abstract] [Full Text] [Related]

  • 8. Critical evaluation of bispecific antibodies as targeting agents for boron neutron capture therapy of brain tumors.
    Liu L, Barth RF, Adams DM, Soloway AH, Reisfeld RA.
    Anticancer Res; 1996 Apr 01; 16(5A):2581-7. PubMed ID: 8917355
    [Abstract] [Full Text] [Related]

  • 9. Rapid and specific targeting of 125I-labeled B lymphocyte stimulator to lymphoid tissues and B cell tumors in mice.
    Riccobene TA, Miceli RC, Lincoln C, Knight Y, Meadows J, Stabin MG, Sung C.
    J Nucl Med; 2003 Mar 01; 44(3):422-33. PubMed ID: 12621010
    [Abstract] [Full Text] [Related]

  • 10. Ultrastructural study of the persistence of colchicine-induced cytological changes in Harding-Passey melanoma.
    Loader KR, Nathaniel EJ.
    Cancer Res; 1978 Jan 01; 38(1):168-76. PubMed ID: 563286
    [Abstract] [Full Text] [Related]

  • 11. Boron neutron capture therapy of intracerebral melanoma using boronophenylalanine as a capture agent.
    Matalka KZ, Bailey MQ, Barth RF, Staubus AE, Soloway AH, Moeschberger ML, Coderre JA, Rofstad EK.
    Cancer Res; 1993 Jul 15; 53(14):3308-13. PubMed ID: 8324742
    [Abstract] [Full Text] [Related]

  • 12. [The formation of melanin in muscle cells after the direct transfer of RNA from Harding-Passey melanoma cells].
    Grässmann A, Grässmann M.
    Hoppe Seylers Z Physiol Chem; 1971 Apr 15; 352(4):527-32. PubMed ID: 5559161
    [No Abstract] [Full Text] [Related]

  • 13. Distribution of 2,2,6,6-tetramethyl-4-oxopiperidine-1-oxyl free radical in normal and neoplastic animal tissues.
    Blagoeva P, Raikov Z, Chernozemsky I, Nikolov I, Yordanov N.
    Cancer Biochem Biophys; 1979 Apr 15; 3(4):169-71. PubMed ID: 233304
    [Abstract] [Full Text] [Related]

  • 14. Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT).
    Maruyama K, Ishida O, Kasaoka S, Takizawa T, Utoguchi N, Shinohara A, Chiba M, Kobayashi H, Eriguchi M, Yanagie H.
    J Control Release; 2004 Aug 11; 98(2):195-207. PubMed ID: 15262412
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Enhancement of semustine-induced cytotoxicity by chlorpromazine and caffeine in a human melanoma xenograft.
    Osieka R, Glatte P, Pannenbäcker R, Schmidt CG.
    Cancer Treat Rep; 1986 Oct 11; 70(10):1167-71. PubMed ID: 3756939
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Thiouracil distribution in mice carrying transplantable melanoma.
    Fairchild RG, Packer S, Greenberg D, Som P, Brill AB, Fand I, McNally WP.
    Cancer Res; 1982 Dec 11; 42(12):5126-32. PubMed ID: 7139615
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.